Molecular imaging and radiotherapy: theranostics for personalized patient management.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed.

1. Metal-Ligand Interactions in Scandium Complexes with Radiopharmaceutical Applications.Inorganic chemistry · 2023
   Article
2. First In Vivo and Phantom Imaging of Cyclotron-ProducedJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
   Article
3. Microfluidics-Coupled Radioluminescence Microscopy forAnalytical chemistry · 2021
   Article
4. A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasms.International journal of medical sciences · 2021
   Article
5. High yield cyclotron production of a novelScientific reports · 2020
   Article
6. Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity.Pharmaceuticals (Basel, Switzerland) · 2019
   Review
7. IntratumoralEJNMMI research · 2019
   Article
8. Prospective ofContrast media & molecular imaging · 2018
   Review
9. The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide PairPharmaceuticals (Basel, Switzerland) · 2017
   Article
10. EJNMMI radiopharmacy and chemistry · 2017
    Article
11. 68Ga-Based radiopharmaceuticals: production and application relationship.Molecules (Basel, Switzerland) · 2015
    Review
12. Positron emission tomography image-guided drug delivery: current status and future perspectives.Molecular pharmaceutics · 2014
    Review
13. Nanobody: the "magic bullet" for molecular imaging?Theranostics · 2014
    Review
14. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.Theranostics · 2014
    Review
15. Prospective of ⁶⁸Ga-radiopharmaceutical development.Theranostics · 2013
    Review
16. Nanotheranostics for personalized medicine.Expert review of molecular diagnostics · 2013
    Review
17. Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Pharmacological reviews · 2013
    Review
18. Lewis acid-assisted isotopic 18F-19F exchange in BODIPY dyes: facile generation of positron emission tomography/fluorescence dual modality agents for tumor imaging.Theranostics · 2013
    Article
19. High-Efficiency Production of Radiopharmaceuticals via Droplet Radiochemistry: A Review of Recent Progress.Molecular imaging
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as